
  
    
      
        Background_NNP
        On_IN the_DT basis_NN of_IN sequence_NN homo_NN logy_NN and_CC similarity_NN of_IN
        three-dimensional_JJ structures_NNS ,_, phosphoprotein_NN phosphatases_NNS
        (_( PPases_NNP )_) have_VBP been_VBN classified_VBN into_IN three_CD families_NNS
        designated_VBN PPP_NNP ,_, PPM_NNP ,_, and_CC PTP_NNP [_NN reviewed_VBN in_IN [_NN 1_CD 2_CD 3_CD ]_NN ._. The_DT
        PPP_NNP and_CC PPM_NNP families_NNS are_VBP comprised_VBN of_IN phosphoserine-_NN and_CC
        phosphothreonine-specific_JJ enzymes_NNS whereas_IN the_DT PTP_NNP family_NN
        consists_VBZ of_IN phosphotyrosine-specific_JJ and_CC dual-specificity_JJ
        enzymes_NNS [_NN 4_CD ]_NN ._. The_DT major_JJ members_NNS of_IN the_DT PPP_NNP family_NN are_VBP
        PP_NNP 1_CD ,_, PP_NNP 2_CD A_DT ,_, and_CC PP_NNP 2_CD B_NNP (_( calcineurin_NN )_) class_NN of_IN phosphatases_NNS ._.
        Protein_NNP phosphatase_NN 5_CD (_( PP_NNP 5_LS )_) ,_, a_DT newer_JJR member_NN of_IN the_DT PPP_NNP
        family_NN ,_, differs_VBZ from_IN the_DT other_JJ Ser_NNP /_NN Thr_NNP phosphatases_NNS in_IN that_IN
        it_PRP contains_VBZ regulatory_JJ and_CC (_( sub_NN )_) cellular_JJ targeting_VBG
        functions_NNS within_IN a_DT single_JJ polypeptide_NN [_NN 5_CD 6_CD 7_CD ]_NN ._. While_IN its_PRP$
        catalytic_JJ core_NN exhibits_VBZ strong_JJ similarity_NN to_TO those_DT of_IN the_DT
        other_JJ members_NNS of_IN this_DT family_NN ,_, its_PRP$ N-_NNP terminus_JJ consists_VBZ of_IN
        three_CD tetratricopeptide_NN repeats_VBZ (_( TPRs_NNP )_) that_WDT are_VBP unique_JJ to_TO
        the_DT PP_NNP 5_CD class_NN ._. TPR_NNP domains_NNS consist_VBP of_IN a_DT series_NN of_IN
        antiparallel_NN amphipathic_JJ α_NN helices_NNS that_WDT bundle_NN together_RB
        through_IN hydrophobic_JJ interactions_NNS to_TO form_VB a_DT cradle-shaped_JJ
        groove_NN ,_, postulated_JJ to_TO be_VB involved_VBN in_IN binding_VBG a_DT number_NN of_IN
        proteins_NNS of_IN regulatory_JJ importance_NN such_JJ as_IN heat_NN shock_NN
        protein_NN 90_CD ,_, a_DT major_JJ cellular_JJ chaperone_NN [_NN 8_CD 9_CD 10_CD ]_NN ._.
        The_DT 
        Apicomplexan_NNP family_NN of_IN parasites_NNS ,_,
        exemplified_VBN by_IN 
        Plasmodia_NNP ,_, are_VBP major_JJ disease_NN agents_NNS
        of_IN humans_NNS ._. As_IN the_DT causative_JJ agent_NN of_IN malaria_NN ,_, 
        Plasmodia_NNP sp_NN ._. alone_RB infects_NNS about_RB 300_CD
        million_CD people_NNS globally_RB and_CC results_NNS in_IN an_DT annual_JJ death_NN toll_NN
        of_IN nearly_RB 2_CD million_CD [_NN 11_CD ]_NN ._. 
        Plasmodium_NNP falciparum_NN (_( Pf_NNP )_) is_VBZ the_DT
        most_JJS virulent_NN of_IN all_DT and_CC causes_NNS fatal_JJ cerebral_JJ malaria_NN ._.
        Because_IN of_IN the_DT continual_JJ emergence_NN of_IN drug-resistant_JJ
        parasites_NNS throughout_IN the_DT world_NN ,_, a_DT need_NN for_IN a_DT fundamental_JJ
        knowledge_NN of_IN the_DT signaling_VBG pathways_NNS of_IN the_DT parasite_NN has_VBZ
        been_VBN recognized_VBN ._. In_IN the_DT recent_JJ past_NN ,_, this_DT has_VBZ led_VBN to_TO the_DT
        identification_NN of_IN a_DT number_NN of_IN 
        Plasmodium_NNP protein_NN phosphatases_NNS ,_, some_DT
        putative_JJ [_NN 12_CD 13_CD ]_NN ,_, others_NNS experimentally_RB demonstrated_VBN
        [_NN e_SYM ._. g_SYM ._. ,_, [_NN 14_CD 15_CD 16_CD ]_NN ]_NN ._. Most_JJS of_IN these_DT phosphatases_NNS resembled_JJ
        the_DT classical_JJ mammalian_JJ PP_NNP 1_CD ,_, PP_NNP 2_CD A_DT ,_, PP_NNP 2_CD B_NNP and_CC PP_NNP 2_CD C_NNP enzymes_NNS [_NN
        12_CD 14_CD 16_CD ]_NN ,_, and_CC some_DT were_VBD potentially_RB novel_NN Ser_NNP /_NN Thr_NNP
        phosphatases_NNS [_NN 13_CD 15_CD 16_CD ]_NN ._.
        In_IN this_DT report_NN ,_, we_PRP describe_VBP the_DT cloning_VBG and_CC
        characterization_NN of_IN a_DT novel_JJ PP_NNP 5_CD phosphatase_NN from_IN Pf_NNP (_( PfPP_NNP 5_LS )_)
        that_WDT contains_VBZ an_DT unusually_RB long_JJ N-_NNP terminal_NN extension_NN that_WDT
        contained_VBD four_CD putative_JJ TPR_NNP motifs_NNS and_CC played_VBD an_DT important_JJ
        role_NN in_IN fatty_NN acid-mediated_JJ activation_NN of_IN the_DT enzyme_NN ._. The_DT
        structural_JJ and_CC biochemical_JJ properties_NNS of_IN PfPP_NNP 5_CD described_VBD
        herein_NN are_VBP hallmarks_NNS of_IN the_DT PP_NNP 5_CD class_NN ,_, and_CC thus_RB establish_VB
        PfPP_NNP 5_CD as_IN a_DT likely_JJ player_NN in_IN parasitic_JJ signal_NN transduction_NN ,_,
        and_CC hence_RB a_DT potential_JJ target_NN for_IN antimalarial_NN drug_NN
        design_NN ._.
      
      
        Results_NNS
        
          Identification_NNP of_IN PfPP_NNP 5_CD cDNA_NN and_CC gene_NN
          To_TO identify_VB new_JJ Ser_NNP /_NN Thr_NNP phosphatases_NNS of_IN Pf_NNP ,_, we_PRP have_VBP
          recently_RB undertaken_VBN a_DT PCR-based_NNP approach_NN ._. At_IN first_JJ ,_, we_PRP
          made_VBD degenerate_VB deoxyoligonuclotide_NN primers_NNS corresponding_JJ
          to_TO the_DT conserved_JJ peptide_NN sequences_NNS GDXHGQ_NNP and_CC GDXVDRG_NNP of_IN
          PPs_NNP [_NN 17_CD ]_NN ._. An_DT approximately_RB 120_CD bp_NN PCR_NNP product_NN ,_,
          obtained_VBN by_IN using_VBG these_DT primers_NNS with_IN the_DT Pf_NNP 3_CD D_NNP 7_CD genomic_JJ
          DNA_NNP as_IN template_NN ,_, was_VBD cloned_VBN in_IN the_DT pGEM-T_JJ vector_NN
          (_( Promega_NNP )_) using_VBG the_DT T_NN /_NN A_DT cloning_VBG strategy_NN ._. Sequencing_NNP of_IN
          individual_JJ clones_NNS revealed_VBD a_DT variety_NN of_IN potential_JJ PPP_NNP
          sequences_NNS in_IN Pf_NNP ,_, one_CD of_IN which_WDT was_VBD an_DT exact_JJ match_NN with_IN a_DT
          putative_JJ open_JJ reading_NN frame_NN (_( ORF_NNP )_) on_IN Pf_NNP chromosome_NN 13_CD in_IN
          the_DT sequence_NN database_NN of_IN the_DT Sanger_NNP Center_NNP (_( Accession_NNP No_UH ._.
          AL_NNP 049185_CD )_) ._. Comparison_NNP of_IN the_DT predicted_VBN primary_JJ structure_NN
          of_IN the_DT protein_NN clearly_RB revealed_VBD its_PRP$ similarity_NN with_IN known_VBN
          members_NNS of_IN the_DT PP_NNP 5_CD family_NN ,_, including_VBG the_DT presence_NN of_IN
          multiple_JJ TPR_NNP domains_NNS (_( Fig_NNP ._. 1_LS and_CC 2_LS )_) ._. Specific_JJ primers_NNS were_VBD
          then_RB made_VBN against_IN this_DT ORF_NNP and_CC the_DT 1578_CD base_NN pair_NN gene_NN
          was_VBD cloned_VBN and_CC confirmed_VBN by_IN sequencing_VBG ._. The_DT same_JJ set_NN of_IN
          primers_NNS were_VBD then_RB used_VBN to_TO amplify_VB the_DT PfPP_NNP 5_CD cDNA_NN sequence_NN
          from_IN a_DT poly_RB (_( A_DT )_) -_: enriched_JJ mRNA_NN population_NN of_IN Pf_NNP strain_NN Dd_NNP 2_CD ._.
          This_DT sequence_NN fully_RB matched_VBD the_DT genomic_JJ Sanger_NNP sequence_NN ,_,
          suggesting_VBG the_DT lack_NN of_IN introns_NNS in_IN the_DT PfPP_NNP 5_CD gene_NN ._.
        
        
          Recombinant_NNP expression_NN of_IN PfPP_NNP 5_CD
          To_TO express_VB the_DT putative_JJ PfPP_NNP 5_CD protein_NN ,_, we_PRP subcloned_JJ it_PRP
          in_IN the_DT bacterial_JJ expression_NN vector_NN pET-_NN 15_CD b_SYM and_CC introduced_VBD
          the_DT plasmids_NNS into_IN 
          E_NNP ._. coli_NNS BL_NNP 21_CD (_( DE_NNP 3_LS )_) ._. As_IN shown_VBN in_IN Fig_NNP ._.
          3_LS ,_, when_WRB induced_VBN with_IN IPTG_NNP ,_, the_DT pET-_NN 15_CD b-_NN PfPP_NNP 5_CD clone_NN
          produced_VBD a_DT polypeptide_NN of_IN approximate_JJ Mr_NNP 70_CD k_NN (_( lane_NN 2_LS )_) ,_,
          which_WDT is_VBZ in_IN excellent_JJ agreement_NN with_IN the_DT calculated_VBN MW_NNP of_IN
          69_CD ,_, 139_CD ,_, considering_VBG that_DT pET-_NN 15_CD b_SYM adds_VBZ a_DT (_( His_PRP$ )_) 
          6_CD tag_NN (_( about_IN 2_CD kDa_NN )_) to_TO the_DT N-_NNP terminus_JJ
          of_IN the_DT recombinant_JJ protein_NN ._. The_DT presence_NN of_IN the_DT (_( His_PRP$ )_) 
          6_CD tag_NN could_MD be_VB confirmed_VBN by_IN anti-_NN His_PRP$
          antibody_NN in_IN immunoblot_NN (_( data_NNS not_RB shown_VBN )_) ._. The_DT His-tagged_NNP
          PfPP_NNP 5_CD was_VBD subsequently_RB purified_JJ through_IN standard_JJ
          nickel-chelation_JJ chromatography_NN (_( Fig_NNP ._. 3_LS ,_, lane_NN 5_LS )_) ._. Using_VBG
          32_CD P-_NNP labeled_VBD histone_NN as_IN substrate_NN under_IN standard_JJ assay_NN
          conditions_NNS (_( in_IN absence_NN of_IN any_DT activator_NN )_) ,_, the_DT specific_JJ
          activity_NN of_IN the_DT recombinant_JJ PfPP_NNP 5_CD was_VBD measured_VBN to_TO be_VB 198_CD
          ±_NN 25_CD nmoles_NNS of_IN 32_CD P_NN /_NN min_NN /_NN mg_NN enzyme_NN ._.
          The_DT deletion_NN mutant_JJ ,_, ΔTPR-PfPP_JJ 5_CD ,_, was_VBD similarly_RB cloned_VBN
          by_IN PCR_NNP using_VBG a_DT primer_NN corresponding_JJ to_TO the_DT internal_JJ
          sequence_NN ,_, and_CC purified_JJ by_IN nickel_NN chelation_NN affinity_NN
          chromatography_NN ._. The_DT deletion_NN mutant_JJ starts_NNS with_IN Met-_NNP 273_CD ,_,
          as_IN described_VBN in_IN Fig_NNP ._. 1_LS ._.
        
        
          Identification_NNP of_IN native_JJ parasitic_JJ PP_NNP 5_CD
          To_TO identify_VB whether_IN PfPP_NNP 5_CD is_VBZ actually_RB expressed_VBN in_IN the_DT
          parasite_NN ,_, cell-free_JJ extracts_NNS of_IN the_DT asynchronous_JJ
          erythrocytic_JJ stage_NN parasites_NNS were_VBD subjected_VBN to_TO standard_JJ
          chromatographic_JJ procedures_NNS that_WDT had_VBD been_VBN previously_RB
          optimized_JJ for_IN human_JJ PP_NNP 5_CD [_NN 18_CD ]_NN ._. Studies_NNPS of_IN mammalian_JJ PP_NNP 5_CD
          have_VBP revealed_VBN that_IN the_DT TPR_NNP domain_NN might_MD act_VB as_IN an_DT
          auto-inhibitory_JJ domain_NN of_IN the_DT phosphatase_NN activity_NN ,_, and_CC
          that_IN tryptic_JJ digestion_NN of_IN PP_NNP 5_CD causes_NNS loss_NN of_IN the_DT TPRs_NNP and_CC
          concomitant_NN stimulation_NN of_IN activity_NN [_NN 19_CD 20_CD 21_CD ]_NN ._. As_IN
          described_VBD under_IN Materials_NNPS and_CC Methods_NNP ,_, the_DT purification_NN
          was_VBD in_IN fact_NN monitored_VBN by_IN assaying_VBG for_IN a_DT trypsin-activated_JJ
          phosphatase_NN with_IN the_DT assumption_NN that_IN PfPP_NNP 5_CD may_MD behave_VB
          like_IN mammalian_JJ PP_NNP 5_CD in_IN this_DT regard_NN [_NN 18_CD 20_CD 21_CD ]_NN ._. As_IN
          mentioned_VBN ,_, the_DT activity_NN peaks_NNS always_RB coincided_VBD with_IN a_DT ~_NN 69_CD
          kDa_NN band_NN in_IN parallel_JJ Western_JJ analyses_NNS of_IN the_DT
          chromatographic_JJ fractions_NNS ._. In_IN SDS-PAGE_NNP ,_, the_DT partially_RB
          purified_JJ fraction_NN contained_VBD a_DT major_JJ polypeptide_NN of_IN the_DT
          expected_VBN size_NN (_( 69_CD kDa_NN )_) (_( Fig_NNP ._. 4_LS ,_, lane_NN 2_LS )_) ._. In_IN Western_JJ blot_NN ,_,
          the_DT rabbit_NN antibody_NN raised_VBD against_IN the_DT purified_JJ
          recombinant_JJ protein_NN also_RB specifically_RB reacted_VBD with_IN the_DT
          native_JJ polypeptide_NN (_( Fig_NNP ._. 4_LS ,_, lanes_NNS 5_CD ,_, 6_CD )_) ._. A_DT similar_JJ
          fraction_NN prepared_VBN from_IN uninfected_JJ erythrocytes_NNS contained_VBD
          very_RB little_JJ protein_NN (_( Fig_NNP 4_CD ,_, lane_NN 3_LS )_) ,_, and_CC did_VBD not_RB react_VB
          with_IN the_DT antibody_NN (_( lane_NN 7_CD )_) ._. A_DT pre-immune_JJ serum_NN served_VBD as_IN
          a_DT negative_JJ control_NN (_( Fig_NNP 4_CD ,_, lane_NN 9_CD )_) ._. As_IN expected_VBN ,_, the_DT
          native_JJ Pf_NNP protein_NN was_VBD about_IN 2_CD kDa_NN smaller_JJR than_IN the_DT
          His-tagged_NNP recombinant_JJ (_( compare_VB the_DT native_JJ band_NN in_IN lanes_NNS
          2_CD ,_, 5_CD ,_, and_CC 6_CD with_IN the_DT recombinant_JJ in_IN lanes_NNS 4_CD and_CC 8_CD )_) ._. Using_VBG
          phosphohistone_NN as_IN substrate_NN ,_, the_DT native_JJ Pf_NNP enzyme_NN
          exhibited_VBN a_DT specific_JJ activity_NN of_IN 210_CD ±_NN 20_CD nmoles_NNS of_IN 32_CD P_NN
          per_IN minute_NN per_IN mg_NN enzyme_NN ,_, which_WDT is_VBZ comparable_JJ to_TO that_DT of_IN
          the_DT recombinant_JJ enzyme_NN ._. Together_RB ,_, these_DT results_NNS
          demonstrated_VBD the_DT equivalence_NN of_IN the_DT native_JJ and_CC
          recombinant_JJ proteins_NNS ,_, and_CC in_IN turn_NN ,_, confirmed_VBD the_DT
          authenticity_NN of_IN the_DT cDNA_NN sequence_NN ._.
        
        
          Primary_JJ structure_NN of_IN PfPP_NNP 5_CD
          When_WRB the_DT predicted_VBD primary_JJ structure_NN of_IN PfPP_NNP 5_CD was_VBD
          aligned_VBN with_IN known_VBN PP_NNP 5_CD sequences_NNS (_( Fig_NNP ._. 1_LS )_) ,_, the_DT following_VBG
          features_NNS were_VBD obvious_JJ ._. First_LS ,_, PfPP_NNP 5_CD contained_VBD the_DT
          catalytic_JJ core_NN found_VBD in_IN all_DT Ser_NNP /_NN Thr_NNP phosphatases_NNS of_IN the_DT
          PPP_NNP family_NN ,_, including_VBG the_DT signature_NN motifs_NNS such_JJ as_IN
          GDXHGQ_NNP ,_, GDFVDRG_NNP ,_, RGNHE_NNP ,_, HGLL_NNP ,_, and_CC SAPNYCD_NNP ,_, to_TO name_VB a_DT few_JJ
          [_NN 22_CD 23_CD ]_NN ._. Site-directed_NNP mutagenesis_NNS and_CC structural_JJ
          studies_NNS in_IN PP_NNP 1_CD and_CC PPλ_NNP have_VBP previously_RB established_VBN the_DT
          roles_NNS of_IN specific_JJ amino_JJ acid_NN residues_NNS in_IN these_DT domains_NNS in_IN
          the_DT various_JJ aspects_NNS of_IN catalysis_NNS ,_, such_JJ as_IN metal_NN ion_NN
          binding_JJ ,_, phosphate_NN recognition_NN ,_, and_CC co-ordination_JJ of_IN
          water_NN molecules_NNS [_NN 24_CD 25_CD 26_CD ]_NN ._.
          While_IN the_DT catalytic_JJ core_NN is_VBZ generally_RB necessary_JJ and_CC
          sufficient_JJ for_IN the_DT phosphohydrolase_NN activity_NN of_IN PPP_NNP
          enzymes_NNS ,_, the_DT residues_NNS outside_IN the_DT core_NN play_NN critical_JJ
          roles_NNS in_IN binding_JJ accessory_JJ proteins_NNS or_CC small_JJ molecules_NNS
          that_WDT modulate_VBP the_DT catalytic_JJ activity_NN [_NN 25_CD 26_CD 27_CD 28_CD 29_CD ]_NN ._.
          Specifically_RB in_IN the_DT PP_NNP 5_CD class_NN ,_, the_DT N-_NNP terminus_JJ has_VBZ been_VBN
          shown_VBN to_TO contain_VB three_CD TPR_NNP motifs_NNS [_NN 5_CD 6_CD 7_CD 8_CD ]_NN ,_, the_DT
          three-dimensional_JJ structure_NN of_IN which_WDT is_VBZ now_RB also_RB
          available_JJ [_NN 8_CD ]_NN ._. Interestingly_RB ,_, the_DT N-_NNP terminal_NN sequence_NN
          of_IN PfPP_NNP 5_CD was_VBD the_DT longest_JJS of_IN all_DT ,_, and_CC seemed_VBD to_TO contain_VB
          four_CD TPR_NNP motifs_NNS instead_RB of_IN three_CD (_( Fig_NNP ._. 2_LS )_) ._. Thus_RB ,_, in_IN
          comparing_VBG the_DT full_JJ sequences_NNS of_IN the_DT PP_NNP 5_CD s_VBZ ,_, only_RB three_CD of_IN
          the_DT four_CD PfPP_NNP 5_CD TPRs_NNP were_VBD aligned_VBN with_IN the_DT others_NNS ,_, and_CC the_DT
          second_JJ TPR_NNP of_IN PfPP_NNP 5_CD was_VBD left_VBN out_RP ._. A_DT detailed_VBN sequence_NN
          analysis_NN of_IN all_PDT the_DT PfPP_NNP 5_CD TPRs_NNP is_VBZ offered_VBN below_IN ._.
          The_DT TPR_NNP motif_NN is_VBZ a_DT degenerate_VB ,_, 34_CD -_: amino_JJ acid_NN repeat_NN
          that_WDT is_VBZ often_RB found_VBN in_IN tandem_JJ arrays_NNS ,_, sometimes_RB separated_VBN
          by_IN spacer_NN sequences_NNS [_NN 9_CD ]_NN ._. We_PRP propose_VBP such_PDT a_DT 22_CD -_: residue_NN
          spacer_NN between_IN the_DT first_JJ two_CD TPRs_NNP of_IN PfPP_NNP 5_CD (_( Fig_NNP ._. 1_LS )_) ._.
          Although_IN no_DT single_JJ amino_JJ acid_NN is_VBZ absolutely_RB invariant_NN in_IN
          all_DT TPRs_NNP ,_, they_PRP do_VBP contain_VB a_DT largely_RB conserved_JJ pattern_NN of_IN
          amino_JJ acid_NN similarity_NN in_IN terms_NNS of_IN size_NN ,_, hydrophobicity_NN ,_,
          and_CC spacing_VBG [_NN 8_CD 9_CD ]_NN ._. Eight_CD amino_JJ acid_NN residues_NNS are_VBP
          critically_RB placed_VBN on_IN the_DT same_JJ face_NN of_IN their_PRP$ respective_JJ
          helices_NNS :_: 4_CD ,_, 8_CD ,_, and_CC 11_CD on_IN the_DT first_JJ helix_NN ,_, and_CC 20_CD ,_, 24_CD ,_, and_CC
          27_CD on_IN the_DT second_JJ [_NN 8_CD 9_CD ]_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 2_LS ,_, residues_NNS
          that_WDT are_VBP identical_JJ or_CC have_VBP similar_JJ hydrophobicity_NN are_VBP
          found_VBN in_IN all_DT four_CD proposed_VBN TPRs_NNP of_IN PfPP_NNP 5_CD in_IN the_DT correct_JJ
          relative_JJ spacing_VBG ._. Moreover_RB ,_, secondary_JJ structure_NN
          prediction_NN suggested_VBD that_IN each_DT PfPP_NNP 5_CD TPR_NNP also_RB has_VBZ the_DT
          potential_NN to_TO form_VB the_DT two_CD conserved_JJ helices_NNS (_( A_DT and_CC B_NNP )_) ,_, as_IN
          marked_VBN in_IN Fig_NNP ._. 2_LS ._. Thus_RB ,_, all_PDT the_DT TPRs_NNP of_IN PfPP_NNP 5_CD may_MD satisfy_VB
          the_DT structural_JJ requirements_NNS of_IN a_DT TPR_NNP motif_NN ._.
          An_DT approximately_RB 34_CD -_: residue_NN stretch_NN following_VBG the_DT last_JJ
          TPR_NNP of_IN PP_NNP 5_CD (_( Fig_NNP ._. 1_LS )_) shows_VBZ weak_JJ similarity_NN to_TO a_DT TPR_NNP motif_NN ._.
          However_RB ,_, alpha-helix_JJ prediction_NN and_CC structure_NN
          determination_NN have_VBP shown_VBN that_IN it_PRP is_VBZ a_DT single_JJ long_JJ helix_NN
          that_WDT extends_VBZ out_IN of_IN the_DT TPR_NNP domain_NN [_NN 8_CD ]_NN ._. Thus_RB ,_, this_DT
          region_NN may_MD not_RB represent_VB a_DT typical_JJ TPR_NNP and_CC therefore_RB ,_, is_VBZ
          simply_RB marked_VBN as_IN "_'' helix_NN "_'' in_IN Fig_NNP ._. 1_LS ._.
        
        
          Auto-inhibitory_NNP role_NN of_IN PfPP_NNP 5_CD TPR_NNP :_: activation_NN by_IN
          polyunsaturated_JJ fatty_NN acids_NNS
          The_DT biochemical_JJ properties_NNS further_RBR confirmed_VBD the_DT
          PP_NNP 5_CD -_: like_IN nature_NN of_IN the_DT Pf_NNP enzyme_NN ._. First_LS of_IN all_DT ,_, members_NNS
          of_IN the_DT PP_NNP 5_CD class_NN are_VBP distinguished_VBN by_IN their_PRP$ profound_JJ
          stimulation_NN by_IN polyunsaturated_JJ fatty_NN acids_NNS [_NN 19_CD 20_CD 21_CD 30_CD
          ]_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 5_LS ,_, the_DT phosphatase_NN activity_NN of_IN PfPP_NNP 5_CD
          increased_VBN with_IN increasing_VBG concentrations_NNS of_IN arachidonic_JJ
          acid_NN and_CC oleic_JJ acid_NN ._. At_IN its_PRP$ highest_JJS ,_, the_DT fatty-acid_JJ
          stimulated_VBN activity_NN was_VBD about_IN 3_CD times_NNS the_DT basal_NN activity_NN
          and_CC was_VBD exhibited_VBN at_IN approximately_RB 70_CD and_CC 80_CD μM_NN of_IN
          arachinodic_JJ and_CC oleic_JJ acids_NNS ,_, respectively_RB ._. In_IN contrast_NN ,_,
          stearic_JJ acid_NN ,_, a_DT saturated_VBN fatty_NN acid_NN ,_, did_VBD not_RB appreciably_RB
          stimulate_VB PfPP_NNP 5_CD activity_NN ._.
          To_TO test_VB the_DT role_NN of_IN TPR_NNP region_NN in_IN this_DT activation_NN ,_, a_DT
          TPR_NNP deletion_NN mutant_JJ of_IN PP_NNP 5_CD (_( ΔTPR-PfPP_JJ 5_LS )_) starting_VBG at_IN the_DT
          Met-_NNP 273_CD was_VBD expressed_VBN with_IN an_DT N-_NNP terminal_NN (_( His_PRP$ )_) 
          6_CD tag_NN ._. The_DT recombinant_JJ protein_NN was_VBD
          expressed_VBN from_IN pET-_NN 15_CD b_SYM clone_NN and_CC purified_JJ by_IN Ni-chelation_NNP
          chromatography_NN (_( Fig_NNP ._. 3_LS ,_, lane_NN 6_CD )_) ._. In_IN SDS-PAGE_NNP analysis_NN ,_,
          ΔTPR-PfPP_JJ 5_CD exhibited_VBN a_DT Mr_NNP of_IN approximately_RB 40_CD k_NN as_IN
          expected_VBN (_( predicted_VBD size_NN of_IN 37_CD ,_, 098_CD for_IN the_DT PP_NNP 5_CD part_NN plus_CC
          about_IN 2_CD ,_, 000_CD for_IN the_DT His_PRP$ 
          6_CD tag_NN )_) ._. Interestingly_RB ,_, the_DT specific_JJ
          activity_NN of_IN the_DT ΔTPR-PfPP_JJ 5_CD enzyme_NN was_VBD about_IN 3_CD -_: times_NNS that_IN
          of_IN the_DT full-length_JJ PfPP_NNP 5_CD without_IN arachidonic_JJ acid_NN (_( 580_CD ±_NN
          35_CD nmoles_NNS of_IN 32_CD P_NN per_IN minute_NN per_IN mg_NN enzyme_NN ;_: Fig_NNP ._. 5_LS )_) ._.
          Moreover_RB ,_, unlike_IN the_DT full-length_JJ enzyme_NN ,_, ΔTPR-PfPP_JJ 5_CD was_VBD
          not_RB activated_VBN by_IN arachidonic_JJ acid_NN ,_, suggesting_VBG that_IN the_DT
          TPR_NNP region_NN is_VBZ required_VBN for_IN the_DT activation_NN ._.
          These_DT results_NNS are_VBP reminiscent_NN of_IN similar_JJ studies_NNS done_VBN
          in_IN other_JJ PP_NNP 5_CD enzymes_NNS in_IN which_WDT mutational_NN inactivation_NN of_IN
          the_DT TPR_NNP domain_NN resulted_VBD in_IN an_DT elevated_VBD basal_NN activity_NN and_CC
          concomitant_NN reduced_VBD response_NN to_TO unsaturated_JJ fatty_NN acids_NNS [_NN
          19_CD ]_NN ._. Such_JJ studies_NNS led_VBN to_TO the_DT proposal_NN that_IN TPR_NNP domains_NNS
          regulate_VB the_DT PP_NNP 5_CD catalytic_JJ region_NN in_IN a_DT negative_JJ manner_NN
          and_CC that_IN the_DT interaction_NN of_IN arachidonic_JJ acid_NN with_IN TPR_NNP
          relieves_NNS this_DT auto-inhibition_JJ ._. This_DT was_VBD further_RBR supported_VBN
          by_IN the_DT demonstration_NN that_DT trypsin_NN cleaved_JJ PP_NNP 5_CD in_IN the_DT
          "_'' hinge_VB "_'' sequence_NN connecting_VBG the_DT TPR_NNP region_NN and_CC catalytic_JJ
          domain_NN ,_, and_CC that_IN such_JJ cleavage_NN produced_VBD a_DT highly_RB active_JJ
          enzyme_NN which_WDT was_VBD refractory_JJ to_TO further_VB activation_NN by_IN
          fatty_NN acids_NNS [_NN 18_CD 20_CD 21_CD ]_NN ._. To_TO test_VB whether_IN this_DT is_VBZ also_RB
          true_JJ of_IN PfPP_NNP 5_CD ,_, we_PRP digested_VBN recombinant_JJ PfPP_NNP 5_CD with_IN
          trypsin_NN ,_, which_WDT resulted_VBD in_IN the_DT production_NN of_IN a_DT
          trypsin-resistant_JJ fragment_NN that_WDT was_VBD very_RB similar_JJ in_IN size_NN
          to_TO ΔTPR-PfPP_JJ 5_CD (_( Fig_NNP ._. 3_LS ,_, lane_NN 7_CD )_) ._. When_WRB assayed_JJ for_IN
          phosphatase_NN activity_NN 
          in_IN vitro_NN ,_, the_DT trypsin-digested_JJ
          PfPP_NNP 5_CD indeed_RB behaved_VBD like_IN ΔTPR-PfPP_JJ 5_CD in_IN that_IN it_PRP was_VBD about_IN
          3_CD -_: fold_VB more_RBR active_JJ than_IN the_DT full-length_JJ enzyme_NN and_CC was_VBD
          not_RB activated_VBN by_IN arachidonic_JJ acid_NN any_DT further_JJ (_( Fig_NNP ._. 5_LS )_) ._.
          Together_RB these_DT results_NNS suggest_VBP a_DT role_NN of_IN PfPP_NNP 5_CD TPR_NNP in_IN
          auto-inhibition_JJ and_CC in_IN fatty_NN acid-mediated_JJ
          activation_NN ._.
        
        
          Okadaic_NNP acid_NN sensitivity_NN of_IN PfPP_NNP 5_CD
          The_DT differential_NN sensitivity_NN of_IN the_DT members_NNS of_IN the_DT PPP_NNP
          family_NN to_TO biological_JJ toxins_NNS has_VBZ been_VBN exploited_VBN as_IN a_DT
          diagnostic_JJ tool_NN in_IN studying_VBG these_DT phosphatases_NNS ._. The_DT
          marine_JJ toxin_NN okadaic_JJ acid_NN (_( OA_NNP )_) ,_, in_IN particular_JJ ,_, inhibits_NNS
          the_DT PP_NNP 2_CD A_DT class_NN of_IN phosphatases_NNS at_IN sub-nanomolar_JJ
          concentrations_NNS (_( IC_NNP 50_CD ~_NN 0_CD ._. 05_CD nM_NN )_) and_CC the_DT PP_NNP 1_CD class_NN in_IN the_DT
          low_JJ nanomolar_NN range_NN (_( IC_NNP 50_CD ~_NN 5_CD -_: 45_CD nM_NN )_) ._. The_DT SAPNYC_NNP motif_NN of_IN
          PPP_NNP enzymes_NNS is_VBZ essential_JJ for_IN OA-binding_NNP ,_, and_CC is_VBZ found_VBN in_IN
          all_DT OA-sensitive_NNP phosphatases_NNS including_VBG PP_NNP 1_CD ,_, PP_NNP 2_CD A_DT ,_, and_CC
          PP_NNP 5_CD [_NN [_NN 25_CD 27_CD 28_CD ]_NN ,_, and_CC references_NNS therein_RB ]_NN ._. This_DT motif_NN
          is_VBZ also_RB present_JJ in_IN PfPP_NNP 5_CD (_( Fig_NNP ._. 1_LS )_) ._. Phosphatases_NNP lacking_VBG
          this_DT motif_NN include_VBP the_DT PP_NNP 2_CD B_NNP and_CC PP_NNP 2_CD C_NNP classes_NNS ,_, which_WDT are_VBP
          thus_RB highly_RB resistant_JJ to_TO OA_NNP ._. PP_NNP 2_CD A_DT contains_VBZ an_DT additional_JJ
          Cys_NNP residue_NN two_CD amino_JJ acids_NNS downstream_JJ (_( underlined_VBD in_IN
          SAPNYCYRCG_NNP )_) ,_, believed_VBN to_TO be_VB important_JJ for_IN the_DT profound_JJ
          sensitivity_NN of_IN this_DT class_NN to_TO OA_NNP [_NN 28_CD ]_NN ,_, and_CC this_DT Cys_NNP is_VBZ
          absent_JJ in_IN PfPP_NNP 5_CD and_CC other_JJ PP_NNP 5_CD enzymes_NNS (_( Fig_NNP ._. 1_LS )_) ._. As_IN shown_VBN
          in_IN Fig_NNP ._. 6_CD ,_, OA_NNP inhibited_VBD PfPP_NNP 5_CD in_IN a_DT dose-dependent_JJ manner_NN ,_,
          with_IN an_DT IC_NNP 
          50_CD of_IN 5_CD ._. 1_CD ±_NN 0_CD ._. 2_CD nM_NN ._. This_DT moderate_JJ
          OA-sensitivity_NNP further_JJ establishes_VBZ the_DT identity_NN of_IN PfPP_NNP 5_CD ,_,
          since_IN other_JJ PP_NNP 5_CD enzymes_NNS also_RB exhibit_NN an_DT IC_NNP 
          50_CD value_NN for_IN OA_NNP in_IN the_DT 4_CD -_: 6_CD nM_NN range_NN [_NN
          18_CD ]_NN ._. The_DT ΔTPR_NN mutant_JJ exhibited_VBN an_DT essentially_RB identical_JJ
          IC_NNP 
          50_CD (_( not_RB shown_VBN )_) ,_, supporting_VBG the_DT notion_NN
          that_IN the_DT TPR_NNP domains_NNS do_VBP not_RB play_VB a_DT direct_JJ role_NN in_IN the_DT
          interaction_NN with_IN OA_NNP ._.
        
        
          PfPP_NNP 5_CD binds_NNS Pf_NNP heat_NN shock_NN protein_NN 90_CD (_( hsp_NN 90_CD )_)
          Hsp_NNP 90_CD is_VBZ a_DT highly_RB conserved_JJ molecular_JJ chaperone_NN
          necessary_JJ for_IN viability_NN and_CC for_IN proper_JJ folding_NN ,_,
          processing_NN ,_, and_CC function_NN of_IN proteins_NNS involved_VBN in_IN several_JJ
          signal_NN transduction_NN pathways_NNS [_NN 31_CD 32_CD ]_NN ._. Interestingly_RB ,_,
          mammalian_JJ hsp_NN 90_CD has_VBZ been_VBN shown_VBN to_TO specifically_RB interact_NN
          with_IN PP_NNP 5_CD ,_, and_CC this_DT interaction_NN may_MD have_VB important_JJ
          consequences_NNS in_IN PP_NNP 5_CD structure_NN and_CC function_NN [_NN 33_CD 34_CD ]_NN ._. An_DT
          hsp_NN 90_CD ortholog_NN has_VBZ been_VBN described_VBN in_IN Pf_NNP [_NN 35_CD ]_NN ,_, but_CC its_PRP$
          function_NN is_VBZ currently_RB unknown_JJ ._. It_PRP was_VBD ,_, therefore_RB ,_, logical_JJ
          for_IN us_PRP to_TO ask_VB whether_IN an_DT interaction_NN between_IN PP_NNP 5_CD and_CC
          hsp_NN 90_CD also_RB occurs_VBZ in_IN Pf_NNP ._. To_TO initiate_VB these_DT studies_NNS ,_, we_PRP
          performed_VBD a_DT co-immunoprecipitation_JJ analysis_NN of_IN Pf_NNP
          extracts_NNS in_IN which_WDT complexes_NNS containing_VBG PP_NNP 5_CD were_VBD first_RB
          precipitated_VBD with_IN anti-_NN PP_NNP 5_CD antibody_NN and_CC the_DT precipitate_NN
          then_RB probed_JJ with_IN anti-hsp_JJ 90_CD antibody_NN in_IN Western_JJ blot_NN ._.
          Results_NNS (_( Fig_NNP ._. 7_CD )_) show_NN that_IN Pfhsp_NNP 90_CD is_VBZ indeed_RB found_VBN in_IN
          complex_JJ with_IN PfPP_NNP 5_CD ,_, suggesting_VBG a_DT potential_JJ role_NN of_IN this_DT
          interaction_NN in_IN the_DT mutual_JJ regulation_NN of_IN these_DT two_CD
          important_JJ proteins_NNS ._. The_DT "_'' control_NN "_'' non-immune_JJ serum_NN did_VBD
          not_RB react_VB with_IN either_DT protein_NN (_( lane_NN 1_LS )_) and_CC did_VBD not_RB
          precipitate_NN hsp_NN 90_CD (_( lane_NN 3_LS )_) ._.
        
      
      
        Discussion_NNP
        We_PRP provide_VBP biochemical_JJ and_CC molecular_JJ evidence_NN for_IN a_DT PP_NNP 5_CD
        protein_NN Ser_NNP /_NN Thr_NNP phosphatase_NN of_IN 
        P_NN ._. falciparum_NN that_WDT has_VBZ the_DT catalytic_JJ
        core_NN of_IN the_DT PPP_NNP superfamily_RB and_CC four_CD tetratricopeptide_NN
        (_( 34_CD -_: residue_NN )_) repeat_NN (_( TPR_NNP )_) domains_NNS (_( Fig_NNP ._. 1_LS ,_, 2_LS )_) ._. We_PRP have_VBP
        therefore_RB ,_, tentatively_RB named_VBD this_DT enzyme_NN PfPP_NNP 5_CD ._. To_TO our_PRP$
        knowledge_NN ,_, PfPP_NNP 5_CD is_VBZ the_DT only_RB TPR-containing_NNP 
        Plasmodium_NNP protein_NN reported_VBD at_IN this_DT
        time_NN ._. These_DT domains_NNS ,_, and_CC the_DT associated_VBN properties_NNS such_JJ as_IN
        activation_NN by_IN unsaturated_JJ fatty_NN acids_NNS are_VBP by_IN far_RB the_DT most_RBS
        noteworthy_JJ features_NNS of_IN PfPP_NNP 5_CD ._.
        Recently_RB ,_, a_DT PP_NNP 5_CD phosphatase_NN was_VBD identified_VBN in_IN 
        Trypanosoma_NNP [_NN 30_CD ]_NN that_WDT contained_VBD the_DT
        prototype_NN PP_NNP 5_CD primary_JJ structure_NN ,_, including_VBG three_CD TPR_NNP
        domains_NNS at_IN the_DT N-_NNP terminus_JJ ._. While_IN mammalian_JJ PP_NNP 5_CD is_VBZ activated_VBN
        10_CD -_: 40_CD fold_VB by_IN arachidonic_JJ acid_NN ,_, the_DT 
        Trypanosoma_NNP PP_NNP 5_CD ,_, like_IN its_PRP$ 
        Plasmodium_NNP counterpart_NN (_( Fig_NNP ._. 5_LS )_) ,_, was_VBD
        also_RB activated_VBN only_RB modestly_RB ,_, about_IN 3_CD -_: fold_VB ._. Although_IN the_DT
        reason_NN behind_IN the_DT lower_JJR activation_NN potential_NN is_VBZ unknown_JJ ,_, at_IN
        least_JJS in_IN PfPP_NNP 5_CD it_PRP correlates_NNS with_IN a_DT similar_JJ fold_VB activation_NN
        following_VBG loss_NN of_IN the_DT TPR_NNP domains_NNS through_IN either_DT
        mutagenesis_NNS or_CC proteolytic_JJ cleavage_NN (_( Fig_NNP ._. 3_LS ,_, 5_LS )_) ._. Thus_RB ,_, it_PRP
        appears_VBZ that_IN the_DT TPR_NNP domains_NNS of_IN the_DT primitive_JJ parasitic_JJ PP_NNP 5_CD
        may_MD be_VB less_RBR auto-inhibitory_JJ that_IN those_DT of_IN their_PRP$ higher_JJR
        eukaryotic_JJ counterparts_NNS ._. Recent_JJ mutational_NN analysis_NN of_IN
        recombinant_JJ PP_NNP 5_CD has_VBZ identified_VBN sequences_NNS important_JJ in_IN
        autoinhibition_NN [_NN 19_CD ]_NN ._. Mutation_NNP of_IN Glu-_NNP 76_CD (_( underlined_VBD in_IN
        the_DT human_JJ PP_NNP 5_CD in_IN Fig_NNP ._. 1_LS )_) whose_WP$ side_NN chain_NN projects_NNS away_RB
        from_IN the_DT TPR_NNP groove_NN ,_, resulted_VBD in_IN a_DT 10_CD -_: fold_VB elevation_NN of_IN
        basal_NN activity_NN ,_, and_CC this_DT Glu_NNP is_VBZ conserved_JJ in_IN both_DT Pf_NNP and_CC 
        Trypanosoma_NNP PP_NNP 5_CD (_( Fig_NNP ._. 1_LS )_) ._. A_DT role_NN of_IN
        the_DT C-_NNP terminal_NN end_NN in_IN autoinhibition_NN was_VBD conjectured_JJ based_VBN
        on_IN the_DT finding_VBG that_DT mutation_NN of_IN Gln-_NNP 495_CD (_( underlined_VBD in_IN Fig_NNP ._.
        1_LS )_) elevated_VBD basal_NN activity_NN by_IN 10_CD -_: fold_VB [_NN 19_CD ]_NN ._. This_DT residue_NN
        is_VBZ also_RB found_VBN in_IN Pf_NNP (_( Gln-_NNP 592_CD )_) although_IN it_PRP is_VBZ not_RB conserved_JJ
        in_IN a_DT number_NN of_IN other_JJ PP_NNP 5_CD sequences_NNS (_( Fig_NNP ._. 1_LS )_) ._. Clearly_RB ,_,
        detailed_JJ mutational_NN analysis_NN of_IN these_DT domains_NNS should_MD shed_VB
        light_JJ on_IN the_DT mechanism_NN of_IN PfPP_NNP 5_CD autoinhibition_NN and_CC the_DT role_NN
        of_IN polyunsaturated_JJ fatty_NN acids_NNS in_IN preventing_VBG it_PRP ._.
        The_DT TPR_NNP motif_NN was_VBD originally_RB identified_VBN as_IN a_DT protein_NN
        interaction_NN module_NN in_IN the_DT cell_NN division_NN cycle_NN (_( CDC_NNP )_)
        proteins_NNS in_IN yeast_NN [_NN 36_CD 37_CD ]_NN but_CC has_VBZ since_IN been_VBN shown_VBN to_TO
        occur_VB in_IN proteins_NNS with_IN diverse_JJ functions_NNS in_IN a_DT variety_NN of_IN
        species_NNS [_NN 9_CD ]_NN ._. The_DT number_NN of_IN the_DT TPR_NNP domains_NNS ,_, the_DT spacing_VBG
        between_IN them_PRP ,_, and_CC their_PRP$ placement_NN in_IN the_DT primary_JJ structure_NN
        of_IN the_DT protein_NN appear_VBP variable_JJ ,_, and_CC the_DT relative_JJ
        contribution_NN of_IN the_DT individual_JJ TPRs_NNP in_IN a_DT given_VBN protein_NN has_VBZ
        not_RB been_VBN studied_VBN ._. At_IN least_JJS four_CD major_JJ kinds_NNS of_IN
        macromolecular_NN complexes_NNS have_VBP been_VBN identified_VBN that_WDT involve_VBP
        TPR_NNP domains_NNS ._. These_DT include_VBP complexes_NNS involved_VBN in_IN anaphase_NN
        promotion_NN ,_, transcription_NN repression_NN ,_, protein_NN import_NN ,_, and_CC
        molecular_JJ chaperoning_VBG [_NN 9_CD 10_CD ]_NN ._. Yeast_NN two-hybrid_JJ analysis_NN
        and_CC 
        in_IN vitro_NN interaction_NN studies_NNS have_VBP
        shown_VBN that_IN the_DT TPR_NNP domain_NN of_IN PP_NNP 5_CD interacts_NNS with_IN the_DT TPR_NNP
        domains_NNS of_IN CDC_NNP 16_CD and_CC CDC_NNP 27_CD ,_, which_WDT may_MD be_VB important_JJ in_IN
        recruiting_VBG PP_NNP 5_CD to_TO the_DT anaphase_NN promoting_VBG complex_JJ (_( APC_NNP )_) and_CC
        to_TO the_DT mitotic_JJ spindles_NNS during_IN cell_NN division_NN (_( 38_CD )_) ._.
        Interaction_NNP of_IN PP_NNP 5_CD with_IN heat_NN shock_NN protein_NN 90_CD ,_, a_DT chaperone_NN ,_,
        has_VBZ received_VBN special_JJ attention_NN because_IN of_IN its_PRP$ potential_JJ to_TO
        regulate_VB a_DT variety_NN of_IN pathways_NNS ._. For_IN example_NN ,_, PP_NNP 5_CD is_VBZ a_DT major_JJ
        component_NN of_IN mature_VBP glucocorticoid_NN receptor_NN complexes_NNS of_IN
        higher_JJR eukaryotes_NNS and_CC appears_VBZ to_TO regulate_VB glucocorticoid_NN
        receptor_NN function_NN 
        in_IN vivo_NN [_NN [_NN 34_CD ]_NN and_CC references_NNS
        therein_RB ]_NN ._. Such_JJ observations_NNS suggest_VBP that_IN PP_NNP 5_CD may_MD act_VB as_IN a_DT
        co-chaperone_JJ for_IN hsp_NN 90_CD and_CC raise_VB the_DT possibility_NN that_DT
        protein_NN dephosphorylation_NN may_MD play_VB an_DT important_JJ regulatory_JJ
        role_NN in_IN protein_NN folding_VBG [_NN 33_CD 34_CD ]_NN ._. Interestingly_RB ,_, recent_JJ
        studies_NNS have_VBP identified_VBN a_DT few_JJ residues_NNS of_IN mammalian_JJ PP_NNP 5_CD
        critically_RB important_JJ for_IN its_PRP$ interaction_NN with_IN hsp_NN 90_CD [_NN 34_CD ]_NN
        ._. As_IN marked_VBD on_IN the_DT human_JJ PP_NNP 5_CD TPR_NNP (_( underlined_VBD in_IN Fig_NNP ._. 1_LS )_) the_DT
        corresponding_JJ residues_NNS are_VBP :_: Lys-_NNP 32_CD ,_, Lys-_NNP 97_CD ,_, and_CC Arg-_NNP 101_CD ._. It_PRP
        is_VBZ notable_JJ that_IN the_DT corresponding_JJ residues_NNS are_VBP also_RB
        conserved_JJ in_IN PfPP_NNP 5_CD TPR_NNP ._. The_DT availability_NN of_IN full-length_JJ and_CC
        TPR-deleted_NNP recombinant_JJ PfPP_NNP 5_CD clones_NNS will_MD now_RB allow_VB us_PRP to_TO
        further_VB investigate_VB the_DT exact_JJ nature_NN of_IN the_DT PfPP_NNP 5_CD -_: Pfhsp_NNP 90_CD
        complexes_NNS ,_, and_CC map_VB the_DT interacting_VBG PfPP_NNP 5_CD residues_NNS through_IN
        site-directed_JJ mutagenesis_NNS ._. Clearly_RB ,_, the_DT discovery_NN of_IN PfPP_NNP 5_CD
        and_CC its_PRP$ interaction_NN with_IN homologous_RB hsp_NN 90_CD will_MD open_VB up_RB new_JJ
        directions_NNS in_IN parasitic_JJ protein_NN /_NN gene_NN regulation_NN and_CC
        signaling_VBG ,_, and_CC may_MD lead_VB to_TO specific_JJ drug_NN targets_NNS ._.
      
      
        Conclusions_NNP
        PfPP_NNP 5_CD represents_VBZ the_DT first_JJ TPR-containing_NNP protein_NN
        discovered_VBN in_IN the_DT 
        Apicomplexan_NNP parasites_NNS ._. In_IN view_NN of_IN
        the_DT essential_JJ role_NN of_IN TPR_NNP domains_NNS in_IN protein-protein_JJ
        interaction_NN ,_, further_JJ studies_NNS of_IN PfPP_NNP 5_CD and_CC its_PRP$ TPR_NNP domain_NN
        will_MD shed_VB new_JJ light_NN on_IN phosphatase_NN regulation_NN and_CC the_DT role_NN
        of_IN PP_NNP 5_CD in_IN these_DT clinically_RB important_JJ parasites_NNS ._. As_IN with_IN
        mammalian_JJ PP_NNP 5_CD ,_, PfPP_NNP 5_CD may_MD also_RB play_VB an_DT important_JJ role_NN in_IN
        cell_NN division_NN through_IN its_PRP$ interaction_NN with_IN parasitic_JJ CDC_NNP
        proteins_NNS ._. Interaction_NNP between_IN the_DT 
        Plasmodium_NNP PP_NNP 5_CD and_CC heat_NN shock_NN protein_NN
        90_CD may_MD reflect_VB a_DT mutual_JJ relationship_NN between_IN protein_NN
        phosphorylation_NN and_CC protein_NN folding_VBG in_IN this_DT parasite_NN ._. The_DT
        role_NN of_IN TPR_NNP in_IN this_DT interaction_NN can_MD be_VB addressed_VBN through_IN
        structure-function_JJ analysis_NN of_IN the_DT recombinant_JJ
        proteins_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          PCR_NNP and_CC other_JJ procedures_NNS
          The_DT following_VBG oligodeoxynucleotide_NN primers_NNS were_VBD
          designed_VBN against_IN the_DT putative_JJ PfPP_NNP 5_CD sequence_NN found_VBD on_IN
          chromosome_NN 13_CD (_( AL_NNP 049185_CD ;_: 
          Plasmodium_NNP
          falciparum_NN chr_NN 13_CD __NN 002073_CD )_) :_:
          ATGTTACACAACCATGATGTAGAAGAAG_NNP ;_: TAAATGTTTTGATACAAATTATGAGC_NNP ._.
          These_DT primers_NNS were_VBD used_VBN to_TO amplify_VB the_DT PfPP_NNP 5_CD gene_NN or_CC the_DT
          cDNA_NN using_VBG the_DT Pf_NNP 3_CD D_NNP 7_CD genomic_JJ DNA_NNP or_CC Dd_NNP 2_CD total_JJ RNA_NNP as_IN
          template_NN with_IN PCR_NNP and_CC RT-PCR_NNP ,_, respectively_RB ._. The_DT RT_NNP
          reaction_NN was_VBD performed_VBN using_VBG AMV_NNP reverse_VB transcriptase_NN ,_,
          and_CC all_DT PCRs_NNP were_VBD performed_VBN with_IN a_DT 15_CD :_: 1_CD mixture_NN of_IN
          Taq_NNP :_: Pfu_NNP polymerase_NN ._. The_DT products_NNS were_VBD cloned_VBN into_IN pGEM-T_JJ
          and_CC confirmed_VBN by_IN sequencing_VBG ._. The_DT genomic_JJ and_CC cDNA_NN
          sequences_NNS were_VBD identical_JJ ._. This_DT sequence_NN was_VBD then_RB
          subcloned_JJ into_IN the_DT XhoI_NNP and_CC BamHI_NNP sites_NNS of_IN the_DT pET-_NN 15_CD b_SYM
          vector_NN by_IN designing_VBG similar_JJ primers_NNS but_CC containing_VBG the_DT
          respective_JJ restriction_NN sites_NNS ._. The_DT TPR_NNP deletion_NN mutant_JJ ,_,
          starting_VBG at_IN Glu-_NNP 274_CD (_( bold_JJ in_IN Fig_NNP ._. 1_LS )_) ,_, was_VBD also_RB amplified_VBN
          in_IN a_DT similar_JJ manner_NN using_VBG specific_JJ primers_NNS ,_, and_CC then_RB
          cloned_VBN ._. Introduction_NNP of_IN the_DT plasmids_NNS into_IN 
          E_NNP ._. coli_NNS BL_NNP 21_CD (_( DE_NNP 3_LS )_) cells_NNS containing_VBG
          the_DT compatible_JJ RIG_NNP plasmid_NN [_NN 39_CD ]_NN ,_, induction_NN of_IN the_DT
          proteins_NNS with_IN IPTG_NNP ,_, and_CC purification_NN through_IN Ni-chelation_NNP
          chromatography_NN were_VBD performed_VBN using_VBG the_DT His-_NNP Bind_NNP kit_NN
          reagents_NNS and_CC procedure_NN (_( Novagen_NNP )_) ._.
          Antibodies_NNP against_IN PP_NNP 5_CD and_CC hsp_NN 90_CD were_VBD raised_VBN in_IN rabbit_NN
          and_CC mouse_NN ,_, respectively_RB ,_, using_VBG standard_JJ procedures_NNS [_NN 40_CD ]_NN
          ._. Fatty_NNP acids_NNS were_VBD purchased_VBN from_IN Sigma_NNP (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._.
          SDS-PAGE_NNP and_CC Western_JJ blot_NN using_VBG chemiluminescence-based_JJ
          detection_NN were_VBD performed_VBN essentially_RB as_IN described_VBN [_NN 15_CD ]_NN
          ._. Immunoprecipitation_NNP of_IN PfPP_NNP 5_CD complexes_NNS followed_VBN by_IN
          immunoblot_NN analysis_NN of_IN the_DT precipitate_NN were_VBD carried_VBN out_IN
          essentially_RB as_IN described_VBN [_NN 34_CD ]_NN ._.
        
        
          Growth_NN of_IN Plasmodiumand_NNP purification_NN of_IN
          PfPP_NNP 5_CD
          
          P_NN ._. falciparum_NN (_( 3_CD D_NNP 7_CD or_CC Dd_NNP 2_LS )_) was_VBD
          grown_VBN in_IN human_JJ A-_NNP positive_JJ erythrocytes_NNS and_CC infected_JJ cells_NNS
          were_VBD harvested_VBN at_IN about_IN 15_CD %_NN parasitemia_NN and_CC lysed_JJ by_IN the_DT
          saponin_NN method_NN essentially_RB as_IN described_VBN [_NN 14_CD 15_CD ]_NN ._. PfPP_NNP 5_CD
          was_VBD partially_RB purified_JJ using_VBG published_VBN procedures_NNS [_NN 18_CD ]_NN
          ._. In_IN brief_JJ ,_, the_DT parasites_NNS were_VBD resuspended_JJ in_IN buffer_NN A_DT
          (_( 50_CD mM_NN Tris-_NNP Cl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 10_CD %_NN glycerol_NN ,_, 1_CD mM_NN DTT_NNP )_) plus_CC 20_CD
          mM_NN NaCl_NNP ,_, 1_CD %_NN Triton_NNP X-_NNP 100_CD ,_, leupeptin_NN (_( 1_CD μg_NN /_NN ml_NN )_) ,_, and_CC
          aprotinin_NN (_( 1_CD μg_NN /_NN ml_NN )_) at_IN an_DT approximate_JJ protein_NN
          concentration_NN of_IN 10_CD mg_NN per_IN ml_NN ._. The_DT suspension_NN was_VBD
          sonicated_JJ and_CC the_DT lysate_NN centrifuged_JJ at_IN 100_CD ,_, 000_CD ×_NN g_SYM for_IN
          30_CD min_NN ._. The_DT supernatant_NN ,_, called_VBN "_'' total_JJ extract_NN "_'' ,_, was_VBD
          subjected_VBN to_TO 45_CD %_NN -_: 60_CD %_NN ammonium_NN sulfate_NN fractionation_NN ._. The_DT
          pellet_NN was_VBD resuspended_JJ in_IN 10_CD ml_NN of_IN buffer_NN B_NNP (_( 20_CD mM_NN HEPES_NNP ,_,
          pH_NN 8_CD ._. 5_CD ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN DTT_NNP )_) ,_, desalted_JJ on_IN a_DT Sephadex_NNP G-_NNP 25_CD
          column_NN equilibrated_JJ with_IN buffer_NN B_NNP ,_, then_RB subjected_VBN to_TO
          sequential_NN chromatography_NN on_IN a_DT 5_CD ml_NN HiTrap_NNP heparin_NN column_NN
          (_( Pharmacia_NNP )_) and_CC then_RB a_DT 5_CD ml_NN HiTrap_NNP Q_NNP column_NN (_( Pharmacia_NNP )_) ._.
          PP_NNP 5_CD activity_NN was_VBD followed_VBN during_IN the_DT purification_NN by_IN
          assaying_VBG trypsin-stimulated_JJ pNPPase_NN activity_NN ._. The_DT
          fractions_NNS were_VBD further_RBR confirmed_VBN by_IN Western_JJ blot_NN using_VBG
          anti-_NN PfPP_NNP 5_CD antibody_NN ._. Parasite_NNP culture_NN was_VBD synchronized_VBN
          essentially_RB as_IN described_VBN earlier_JJR [_NN 15_CD ]_NN ._.
        
        
          Phosphatase_NNP assay_NN
          Phosphatase_NNP activity_NN against_IN pNPP_NN or_CC phosphohistone_NN
          substrates_NNS was_VBD determined_VBN essentially_RB as_IN described_VBN
          previously_RB ._. Standard_JJ assays_NNS were_VBD performed_VBN in_IN buffer_NN A_DT
          containing_VBG 1_CD mM_NN EDTA_NNP ,_, and_CC additional_JJ activators_NNS or_CC
          inhibitors_NNS were_VBD added_VBN only_RB where_WRB mentioned_VBN ._. Reactions_NNP
          were_VBD incubated_JJ at_IN 37_CD °_NN C_NNP ._. 32_CD P-_NNP labeled_VBD phosphohistone_NN was_VBD
          made_VBN as_IN described_VBN [_NN 14_CD 15_CD 18_CD ]_NN ._. When_WRB using_VBG
          phosphohistone_NN as_IN substrate_NN ,_, reactions_NNS were_VBD carried_VBN out_IN
          in_IN 80_CD μl_NN followed_VBN by_IN quantification_NN of_IN the_DT liberated_VBD 32_CD Pi_NNP
          by_IN phosphomolybdate_NN extraction_NN assay_NN [_NN 14_CD 15_CD 18_CD ]_NN ._.
          Reactions_NNP were_VBD followed_VBN with_IN time_NN ,_, and_CC results_NNS were_VBD
          corrected_VBN by_IN subtraction_NN of_IN the_DT corresponding_JJ values_NNS from_IN
          an_DT enzyme-free_JJ reaction_NN ._. When_WRB 
          p_NN -_: nitrophenylphosphate_NN was_VBD used_VBN as_IN
          substrate_NN (_( at_IN 10_CD mM_NN )_) ,_, the_DT reaction_NN was_VBD scaled_VBN up_IN to_TO 200_CD
          μl_NN ,_, and_CC the_DT liberated_VBD 
          p_NN -_: nitrophenol_NN was_VBD quantitated_JJ by_IN
          measurement_NN of_IN absorbance_NN at_IN 415_CD nm_NN [_NN 14_CD 23_CD ]_NN ._.
          Phosphatase_NNP reactions_NNS were_VBD routinely_RB initiated_VBN with_IN the_DT
          addition_NN of_IN substrate_NN ._. Dephosphorylation_NNP was_VBD kept_VBN to_TO less_JJR
          than_IN 10_CD %_NN of_IN the_DT total_JJ phosphorylated_JJ substrate_NN ,_, and_CC the_DT
          reaction_NN was_VBD linear_JJ with_IN respect_NN to_TO enzyme_NN concentration_NN
          and_CC time_NN ._. When_WRB using_VBG potential_JJ activators_NNS (_( e_SYM ._. g_SYM ._. ,_, fatty_NN
          acids_NNS )_) or_CC inhibitors_NNS (_( e_SYM ._. g_SYM ._. ,_, okadaic_JJ acid_NN )_) ,_, they_PRP were_VBD
          added_VBN to_TO the_DT enzyme_NN mixture_NN 10_CD minutes_NNS prior_RB to_TO
          initiating_VBG the_DT reaction_NN with_IN the_DT addition_NN of_IN substrate_NN [_NN
          14_CD ]_NN ._.
        
      
    
  
